Riskpilot← Back to searchSign inGet full accessVenturakliniken AB
ABActiveOrg 5591644538Gamla Värmdövägen 5Non-specialised wholesale trade · NACE 4690Est. 20184 employees
Revenue 2025
SEK 4,5M
+52% vs 2024
EBITDA margin
14.0%
+93% vs 2024
Equity ratio
40.2%
Financial strength
Net profit 2025
SEK 273K
+355% vs 2024
| Revenue | SEK 4,5M | +52% |
| EBITDA | SEK 629K | +93% |
| Net profit | SEK 273K | +355% |
| Total assets | SEK 1,6M | +34% |
| Equity | SEK 654K | +72% |
| Employees | 4 | — |
Legal name
Venturakliniken AB
Org number
5591644538
Legal form
Aktiebolag
NACE code
4690 · Non-specialised wholesale trade
Founded
2 juli 2018
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva tjänster inom skönhet, sjukvård och friskvård, handel med skönhetsartiklar, bedriva utbildningsverksamhet inom skönhet samt idka annan därmed förenlig verksamhet.
Address
Gamla Värmdövägen 5
Email
info@venturakliniken.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 602 | 2 626 | 2 796 | 2 963 | 4 500 |
| Staff expenses | — | −1 633 | −1 727 | −1 745 | −2 446 |
| EBITDA | 138 | 301 | 334 | 326 | 629 |
| Depreciation & amort. | −127 | −224 | −221 | −238 | −272 |
| EBIT | 11 | 77 | 113 | 88 | 357 |
| Net financials | −1 | −18 | −25 | −8 | −8 |
| Profit before tax | 10 | 59 | 88 | 80 | 349 |
| Tax | −4 | −21 | −18 | −20 | −76 |
| Net profit | 6 | 38 | 70 | 60 | 273 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 830 | 1 370 | 1 298 | 1 218 | 1 627 |
| Equity | 212 | 250 | 320 | 380 | 654 |
| Long-term debt | 468 | 778 | 649 | 449 | 317 |
| Short-term debt | 150 | 342 | 329 | 389 | 657 |
| Total debt | 618 | 1 120 | 978 | 837 | 974 |
EBITDA margin
14.0%
This company
15.8%
Market median
-11% vs market
20212025
Equity ratio
40.2%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
41.8%
This company
18.4%
Market median
+127% vs market
20212025
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20212025
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20212025
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Venturakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofie Nicole Katarina Lindholm | Chairman | 0 companies |
| Eva Katarina Lindholm | Deputy Board Member | 0 companies |
| Simon Olof Karl Aspelin | Board of Directors | 0 companies |